Company news: J&J, Bayer and Dendreon
An FDA advisory panel recommended giving a thumbs down to J&J/Bayer's anticoagulant Xarelto (rivaroxaban) for use in patients with atrial ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.